GP views on implementing the Cytosponge in Primary Care

This post is from the BEST3 event website, available here. Stay tuned over the coming weeks for more posts about the results from the BEST3 trial!

Learn about the experiences of doctors and nurses trialling the Cytosponge to detect Barrett’s oesophagus in primary care and the processes, benefits and issues that may need to be considered in a future where the Cytosponge is used as part of routine care.

Dr Fiona Walter is the leader of the Cancer Group in the Primary Care Unit at the University of Cambridge. The Cancer Group’s objective is to deliver world-class research focusing on the cancer pathway, from prevention, screening, early detection and diagnostics to post-treatment care; we also focus on translating genetics advances into primary care. Dr Richard Roope is the lead GP at Cancer Research UK. Experienced Leader with a demonstrated history of working in the medical practice industry, particularly in the areas of prevention and early diagnosis of cancer together with the delivery of cancer care.

The views expressed are those of the author. Posting of the blog does not signify that the Cancer Prevention Group endorse those views or opinions.

Share this Page

Subscribe to our mailing list

About Jane Rigney 92 Articles
This post is written by Jane Rigney. Jane is a Clinical Project Manager in the Cancer Prevention Group. She oversees numerous projects, including cancer screening projects, our Patient and Public Involvement (PPI) and general communications.